How long will the side effects of adagrasiib last?
Adagrasib is a targeted therapy drug mainly used to treat KRAS G12C mutation-positive non-small cell lung cancer (NSCLC). Although it demonstrates clinically significant therapeutic effects, like all medications, adagrasiib may cause side effects. The duration of side effects varies from person to person and is often related to the patient's medical condition, the dose of the drug, and how well the drug is tolerated.
Common side effects of adagrasib include fatigue, decreased appetite, diarrhea, nausea, and abnormal liver function. For most patients, these side effects are mild to moderate and are noticeable early in the medication. Generally, these side effects resolve as the patient adjusts to the medication, usually lasting anywhere from a few days to a few weeks. Side effects may be noticeable, especially in the first few weeks of treatment, but usually lessen or disappear as the patient's body adapts.
For some patients, side effects may last longer, especially if the side effects of the drug are severe. For example, abnormal liver function or lung problems may require more time to manage and recover. If a patient experiences persistently high levels of side effects, doctors may adjust the treatment regimen or dose, or even briefly stop taking the drug, to help the patient recover. The duration of side effects is closely related to the patient's overall health. Elderly patients or patients with other underlying diseases may take longer to recover.
Side effects of adagrasiib may also be temporary, and some may disappear as treatment continues. For example, some patients may experience symptoms such as nausea or diarrhea gradually lessening or disappearing completely after several weeks of treatment. In this case, the doctor may recommend that the patient take some symptomatic measures, such as taking anti-nausea medications or changing dietary habits, to relieve symptoms. However, if side effects persist and affect quality of life, patients should communicate with their doctor promptly to seek the possibility of adjusting the treatment plan.
References:https://www.krazati.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)